Indometacin Accord-Uk

Indometacin, the active ingredient in Indometacin Accord-Uk, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as a rectal suppository for local administration. It is used to relieve pain and reduce inflammation in conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout attacks and other musculoskeletal and systemic inflammatory diseases.

GNH USA supplies Indometacin Accord-Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution.

Indometacin is an NSAID that reduces inflammation by inhibiting prostaglandin synthesis, and it is indicated for several rheumatologic and gout conditions. - Rheumatoid arthritis: reduces joint pain, swelling and stiffness. - Osteoarthritis: alleviates chronic joint discomfort and improves mobility. - Ankylosing spondylitis: diminishes spinal inflammation and pain. - Acute gout attacks: rapidly relieves severe joint pain and swelling. - Pain and inflammation: provides symptomatic relief in various inflammatory disorders.

Indometacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or pruritus. - Elevated liver enzymes. - Mild renal function changes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe hepatic injury or hepatitis. - Acute renal failure or interstitial nephritis. - Cardiovascular events such as myocardial infarction. - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis). - Blood dyscrasias (e.g., agranulocytosis, thrombocytopenia).

Before using Indometacin, consider the following safety measures. - Renal function: assess baseline kidney status and monitor during therapy. - Hepatic health: evaluate liver enzymes prior to initiation. - Cardiovascular risk: use cautiously in patients with heart disease or hypertension. - Gastrointestinal protection: consider co‑prescribing a proton‑pump inhibitor for high‑risk individuals. - Pregnancy and lactation: avoid unless benefits outweigh potential risks. - Store at ambient temperature: keep in the original package, protect from moisture and direct sunlight.

Indometacin can interact with several medicines; monitoring is essential.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Lithium: elevated lithium levels leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may exacerbate fluid and electrolyte disturbances. - Methotrexate: reduced clearance and potential toxicity.